Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05346796 · ClinicalTrials.gov registry record · NA

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

A NA study of Cancer, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT05346796 is a NA study of Cancer that is actively recruiting participants, run by Indiana University. The registered enrollment target is 250 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05346796, a NA study of Cancer, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

To understand the effectiveness and implementation of the SCP-PHR, we will conduct a hybrid type 1 effectiveness-implementation trial consisting of the following components: (A) a randomized clinical effectiveness trial, and (B) a mixed methods implementation study.

Conditions Studied

Interventions

  • BEHAVIORAL Survivorship Care Plan-Personal Health Record (SCP-PHR)

Study Locations (1)

Indiana

  • Indiana University School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2022-09-09
Est. Completion 2027-05-31
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05346796

The ClinicalTrials.gov registry entry for NCT05346796 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Survivorship Care Plan-Personal Health Record (SCP-PHR) is the first listed.

NCT05346796 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05346796 about?

NCT05346796 is a clinical study titled "Survivorship Plan HEalth REcord (SPHERE) Implementation Trial". To understand the effectiveness and implementation of the SCP-PHR, we will conduct a hybrid type 1 effectiveness-implementation trial consisting of the following components: (A) a randomized clinical effectiveness trial, and (B) a mixed methods implementation study.

What is the current status of trial NCT05346796?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2022-09-09. Estimated completion is 2027-05-31.

What conditions does trial NCT05346796 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05346796?

The interventions under investigation include: Survivorship Care Plan-Personal Health Record (SCP-PHR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05346796?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05346796 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.